Spadel SA

Consumer Defensive · EUR · EBR

SPAT212

Price

€356

+7.88%

Cap

€1.39B

Earnings

—

30d Trend

+36.9%

0OH1

Loading chart data...

0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

MODERATE

Risk Level31

Quality47

Momentum80

Technical54

Fundamentals38

Raw weighted: 55×Macro 0.99 (−1%)=54

RISK

31/100

90d Volatility

9.1%Low

ATR %

1.5%Normal

Max Drawdown (1Y)

-20.0%Normal

QUALITY

47/100

ROE (avg)

0.2%Weak

Piotroski F-Score

6/9Average

Debt/Equity

0.32Low leverage

Margin Stability

CV 20.5%Volatile

Accruals

-9.6%Cash earnings

Interest Coverage

1.4xTight

MOMENTUM

80/100

12-1M Momentum

+41.4%Strong uptrend

6-1M Momentum

+65.5%Positive

1M Return

+0.0%Stable

Relative Strength

-0.5% vs sectorIn-line

TECHNICAL

54/100

RSI (14)

83.7Overbought

Price vs SMA200

+24.0%Bullish trend

MACD

+0.03Bullish momentum

Bollinger Band

93%Near upper band

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

1.000Clean trend

FUNDAMENTALS

38/100

EV/EBIT

102.1Expensive

P/S

2.5Fair

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months58

3-12 months ★72

1-5+ years54

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate Spadel SA at 54/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 80/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (80) and low-risk profile are the primary strengths. I note that fundamentals is the weakest area at 38/100 — this warrants monitoring. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 54/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.